skip to main content
Show Results with:

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Smolen, Josef S et al.

The lancet. Volume 393:Issue 10188 (2019); pp 2303-2311 -- Elsevier

Online access

Searching Remote Databases, Please Wait